Qi Chen

机构：BGI Group (China), Beijing Normal-Hong Kong Baptist University, Hong Kong Baptist University, BGI Research · ORCID：0000-0002-0658-7629

发表论文 122 篇 · 总被引 3007 次 · h-index 31

代表论文

• Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2023 · The Lancet Respiratory Medicine · 被引 73)
• Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies (2023 · Nano Today · 被引 43)
• Polysaccharide of Asparagus cochinchinensis (Lour.) Merr regulates macrophage immune response and epigenetic memory through TLR4-JNK/p38/ERK signaling pathway and histone modification (2023 · Phytomedicine · 被引 31)
• Interplay of human gastrointestinal microbiota metabolites: Short-chain fatty acids and their correlation with Parkinson’s disease (2024 · Medicine · 被引 24)
• Intervention of Asprosin Attenuates Oxidative Stress and Neointima Formation in Vascular Injury (2024 · Antioxidants and Redox Signaling · 被引 15)
• Spatiotemporal Transcriptomic Profiling Reveals the Dynamic Immunological Landscape of Alveolar Echinococcosis (2025 · Advanced Science · 被引 11)